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typhosus reacting factors of the phenomenon of local skin reactivity can be specifically neutralized in multiple proportions by immune sera in vitro and in vivo. If various amounts of a toxic filtrate are titrated against a constant amount of immune serum it is possible to determine the largest amount of filtrate which is consistently neutralized (i.e. in all rabbits tested) by this amount of serum, and thus to express quantitatively the neutralizing potency of the serum ("CN" titer). If the titration is continued beyond the CN titer (i.e. in greater quantity of toxin) there is usually observed a rather protracted zone of irregular neutralization ("IN" titer) in which the percentage of positive rabbits is considerably lower than in the control group. There is evidently present in these serum-filtrate mixtures a sufficient amount of nonneutralized toxic substance to elicit reactions in rabbits of high susceptibility to the phenomenon. If still larger amounts of toxic filtrate are titrated one arrives at a point where the addition of serum produces no effect. It is clear that the CN titer,--which indicates how many units of toxic filtrate are completely neutralized by a given amount of serum,--is fairly well demarcated. The results obtained by the determination of the IN titer (i.e. of the largest number of units irregularly neutralized by a given amount of serum) are less accurate because of the individual fluctuations in susceptibility of normal rabbits to the phenomenon.
When considerable data had been accumulated concerning the neutralization of B. typhosus toxic substances and the phenomenon of 711 LOCAL SKIN REACTMTY TO BACTERIAL FILTRATES local skin reactivity had been also successfully produced with meningococcus culture filtrates (7) , an attempt was made to study the neutralizing potency of antimeningococcus horse sera in order to obtain a laboratory method for the evaluation of the curative effect of these sera. It became evident from these studies, however, that among the various batches of therapeutic sera tested, none was sufficiently powerful to produce consistent neutralization similar to that obtained in the work on B. typhosus. It was then decided to compute the potency by the determination of the IN titer. This was done by finding the highest dilution of a serum capable of inhibiting reactions in at least three out of five rabbits injected with doses which elicited reactions in about 75 per cent of control rabbits (8) . At the same time the immunization of horses was begun in an effort to develop a serum of higher neutralizing potency. The immunization consisted of subcutaneous injections of toxic filtrates and intravenous injections of heat-killed and live cultures. With considerable difficulties, sometimes shortly after the beginning of immunization, sometimes after many months, it was occasionally possible to obtain a serum which neutralized consistently a fairly large number of toxic units. In these determinations there was again adopted the above described titration of various amounts of toxic units against constant amounts of serum (i.e. 0.25 cc.) (9).
However, further studies brought out the curious fact that in certain sera of a low CN titer the IN titer appeared quite high. Moreover, if multiples of 0.25 cc. were tested, the CN titer did not increase proportionately, a fact illustrated by the following example:
0.25 cc. of antimeningococcus horse serum H7 Bl~0 showed complete neutralization of 15 toxic units and irregular neutralization of 40 units. 1 cc. of the same serum showed irregular neutralization of 25 units. This is in striking contrast to observations made with other immune sera (i.e. antityphoid and anticoli horse sera), which showed complete neutralization in multiple proportions. It seemed possible that the inability of antimeningococcus sera to neutralize completely the toxic factors in multiple proportions may be due to the lack of some auxiliary factor, perhaps non-specific in nature. A search was made for this hypothetical auxiliary factor. This was done by studying the neutralization of meningococcus reacting factors by means of mixtures of antimeningococcus sera with heterologous immune sera which by themselves were capable of complete neutralization in multiple proportions of their homologous toxic substances. The results of the work are embodied in this paper.
EXPERIMENTAL
Tables I and II present a summary of experiments on neutralization of the reacting factors of various serological groups of meningococcus by means of polyvalent antirneningococcus horse sera and also by means of mixtures of these sera with various normal and heterologous immune sera.
On the morning of the experiment the serum mixtures were made in proportions indicated in the tables. These were kept for from 1 to 2 hours at room temperature. The technique of neutralization experiments was the same as described before (9) , except that each test was done on three instead of four rabbits. If no reactions were obtained in the three rabbits tested, the result was considered as showing consistent neutralization of reacting factors (CN). If one of three rabbits showed a reaction the result was recorded as "irregular neutralization" (IN). If two of three or all rabbits showed reactions there was recorded "no neutralization" ("NN").
As is seen from Table I , antimeningococcus horse sera tested in various amounts against filtrates of two strains of Group I, of one non-grouped patient's strain ("Fabio"), and of one Group III strain gave only irregular neutralizations. The larger the amount of serum used, the higher was the IN titer. Mixtures of the various heterologous sera indicated in the table and also of two batches of normal horse serawith the same antimeningocococcus sera also showed only irregular neutralizations.
As is seen in Table II , mixtures of antimeningococcus horse sera with anticoli horse serum displayed a remarkable neutralizing potency. First, these mixtures exhibited a substantial increase in the IN titer (see Table I , Groups 2 and 11 and Table II, Groups 2 and 16); second, they showed complete neutralization of large numbers of toxic units; and, third, they differed in their potency for filtrates of various serological groups (Table II , Groups 8, 9, 10, and 27).
As illustrated by Groups 1 to 10 of Table II , it was possible to determine the CN titers of the mixtures. Thus, if a given mixture 
Group III (44 B) 0.8 " " 0. 6 Group I (44 D) Table II also includes data on the reciprocal relationships between the anticoli and antimeningococcus horse sera.
As is seen from Groups 11 to 22, the anticoli horse serum was by itself capable of giving complete neutralization of meningococcus reacting factors. The neutralizing proPertY of this serum, however, differed in several respects from the specific antibody of antimeningococcus serum:--It had no agglutinins and precipitins for meningococcus (unrecorded experiments); it neutralized the toxic factors of both serological Groups I and III to the same degree; and it was capable of complete neutralization in multiple proportions.
The next step was to determine whether the high complete neutralization obtained with the mixtures described was due to summation of neutralizing titers of sera making up the mixtures.
Inasmuch as 0.1 and 0.5 cc. of anticoli horse Serum Hs0 Bliss contain about 15 and 45 CN units, respectively, it follows that, should there be summation of titers, then a mixture consisting of 0.9 cc. of antimeningococcus Serum Hs B1251 and 0.5 cc. of Serum Hs0 Bliss must have a higher titer than a mixture consisting of the same amount of the antimeningococcus serum and only 0.1 cc. of Serum H60 Bliss. However, as is seen from Groups 23 to 26, both mixtures remained of the same titer. Similarly, in case of summation of titers, any mixture containing 0.6 cc. of anticoli horse Serum H60 Bliss should have at least 50 neutralizing units irrespective of the titer of the antimeningococcus serum. But, as is seen from Groups 1 to 3 and 27, a mixture consisting of 0.4 cc. of antimeningococcus Serum H7 Blls9 and 0.6 cc. of anticoli horse Serum He0 Bl188 gave a CN titer of 115 units, while a mixture consisting of 0.4 cc. of antimeningococcus Serum H7 Bl~20 and 0.6 cc. of the same anticoli serum gave no neutralization of 50 units. As is seen from Groups 3 and 4 of Table   I and Group 35 of Table II , the antimeningococcus Serum H7 Blls9 had a higher IN titer than Serum H7 B1220.
From the data thus far presented, therefore, the following conclusions can be drawn:
1. The high CN titer of mixtures of antimeningococcus and anticoli sera is not due to mere summation of titers of both sera.
2. The addition of anticoli serum to antimeningococcus serum of a low neutralizing potency does not bring about any increase in potency of the mixture. Moreover, the independent neutralizing potency of the anticoli serum seems t'o become abolished altogether when mixed with an aritimeningococcus serum poor in neutralizing antibodies.
3. The addition of anticoli serum to an antimeningococcus serum of a high IN titer results in a high CN titer of the mixture.
These conclusions can be further supported by experiments with Groups 28 to 44 of Table II. In these experiments there was tested the neutralizing potency of various amounts of antimeningococcus Serum H7 B1202 and of mixtures of this serum with diluted and undiluted anticoli horse Serum H60 B1188. As could be expected, various amounts of antimeningococcus serum alone gave irregular neutralizations except when tested with small numbers of toxic units. The addition of 0.1 cc. of anticoli serum previously diluted 1 : 3 had no effect on neutralizing potency. Mixtures of amounts as small as 0.3 and 0.6 cc. of antimeningococcus serum with 0.1 cc. of undiluted anticoli serum did not result in any noticeable increase of the CN titer. In spite of the fact that the latter amount of anticoli serum could neutralize completely about 15 toxic units and 0.3 and 0.6 cc. of antimeningococcus serum could neutralize completely 10 and 15 units, respectively, the mixture of 0.3 cc. of antimeningococcus serum with 0.1 cc. of undiluted anticoli serum neutralized completely less than 8 units, and the mixture of 0.6 cc. of antimeningococcus serum with the above amount of anticoli serum neutralized completely only 15 units, i.e. the same number of units which could be neutralized independently by either ingredient of the mixture. However, when 0.1 cc. of undiluted anticoli serum was added to 0.9 cc. of antimeningococcus serum, the mixture gave complete neutralization of 35 toxic units, although this amount of antimeningococcus serum gave independently only irregular neutralization of 20 units.
From these observations it is seen again that the anticoli serum does not exhibit its independent neutralizing potency when mixed with antimeningococcus serum containing neutralizing antibodies of low concentration (0.3 cc. of HTB120~) ; that it produces no effect when added to a somewhat larger amount of antimeningococcus antibodies (i.e. 0.6 cc. of H7 Bl~02); and that it converts (beyond its own neutralizing potency) irregular neutralization into complete neutralization when added to a sufficient concentration of antimeningococcus antibodies capable of irregular neutralization.
For these reasons it may be assumed that the anticoli serum contributes some auxiliary factor to the specific antibody + antigen combination and enters with it into an intricate relationship.
Further studies were made in order to define closer the nature of the auxiliary factor in the anticoli horse serum.
The following horse sera were tested for complement and anticomplementary properties, namely: anticoli Serum H60Bllss; normal Serum 176/177; antimeningococcus Sera HTB118~, HTB1189, and HTBl~02.
Amounts of each serum tested for complement were 0.01, 0.05, 0.1, and 0.2 cc. These amounts were each mixed with 2 units of sheep red blood cell "amboceptor" Test//.--In this test the various amounts of sera were mixed each with 1 unit of guinea pig complement and 0.2 cc. of beef heart antigen used for Wassermann tests. The rest of the technique and the results were the same as in Test I.
Heating of the sera at 56 ° for 30 minutes completely removed the anticomplementary property.
These experiments established the fact that the auxiliary factor is not in the nature of complement and has no apparent relation to the anticomplementary property of sera.
In Table III there are summarized tests for the auxiliary factor in various bleedings of several horses immunized with B. coli cultures and culture filtrates. These tests were carried out in the manner described on page 713.
The sera tested were added to a given antimeningococcus serum in the proportion 1:10. Two antimeningococcus sera, H~ BI2o~ and H7 B1220, were employed alternately. The amounts of Group III toxic filtrate used were 35 and 90 units respectively, completely neutralized by mixtures of these sera with anticoli horse serum H60 Bl188.1 (See Table II.) 1The CN titer of 9 parts of Hr B120~ -I-1 part H0o Bliss was 35 units. The CN titer of mixture of 9 parts of Hr B12.oo -I-1 part H~o B118s exceeded 90 units.
The horses were immunized as follows: Horse 20.--Immunization began 7/26/29. The first dose was a subcutaneous injection of 10 cc. of "B. coll polyvalent toxin." The latter consisted of a mixture of filtrates of 5 day old tryptic digest broth cultures of fourteen strains. Two strains were rough. The remaining strains were smooth. 0.2 cc. of potassium alum was added to the filtrate before injection. All the injections were made at weekly intervals. The first 2 months the horse received only subcutaneous !njec tions. The doses were gradually increased so that on 9/26/29 there was injected subcutaneously 200 cc. of the filtrate. From this date the horse was immunized weekly both subcutaneously with the filtrate and also intravenously with "polyvalent heat-killed B. coli vaccine." The latter consisted of a mixture of the same strains employed for preparation of the filtrates. The first intravenous dose was 100,000,000 organisms. There was also a gradual increase with each subsequent injection. On 11/26/29 the intravenous dose of one-half billion organisms was Table III .
Horse 101.--Immunization of this horse was less intensive. It began 9/29/31 and continued at weekly intervals. The first subcutaneous dose was 5 cc. of the "polyvalent B. coli toxin." The subcutaneous doses were gradually increased so that 4/2/31 the horse received 20 cc. of the filtrate. From 4/9 to 5/9/31 the horse received both subcutaneous injections of the "polyvalent B. coli toxin" and intravenous injections of the "polyvalent heat-killed B. coli vaccine." Thesubcutaneous dose of 85 cc. was reached on 5/9/31. The intravenous doses were also gradually increased with each injection. The first intravenous dose was 300,000,000 organisms. On 5/9/31 the horse received intravenously 800,000,000 organisms.
As is seen from Table III, the auxiliary factor described is in the nature of an antibody, the production of which is stimulated by immunization with B. coli heated cultures and culture filtrates.
The antibody appears shortly after the beginning of immunization. The length of time necessary, however, for its development differs in horses under the same treatment. Thus, after 10 weeks of immunization the antibody was absent in Horse 2, but already present in Horse 8. The majority of horses developed the antibody in 8 to 10 weeks. The antibody also disappeared in Horses 20 and 60 during the process of immunization. After the disappearance of the antibody, Horse 60 was rested intermittently for 9 weeks. 3 weeks of immunization following the last period of 3 weeks rest again stimulated the production of the ~ntibody.
The question of what happens to the anticoli antibody simultaneously with these fluctuations in auxiliary antibody will be taken up subsequently.
DISCUSSION AND CONCLUSIONS
The present paper embodies data concerning a certain antibody auxiliary to neutralization of meningococcus reacting factors.
The auxiliary antibody is not complement and has no apparent relationship to the anticomplementary property of horse sera.
The antibody is produced by immunization of horses with B. coli heat-killed cultures and culture filtrates. It appears shortly after the beginning of immunization and it may disappear during the process of immunization. Horses in which the antibody disappears can regain their power of producing it after a few weeks of immunization, following a period of rest.
The auxiliary antibody is absent from other heterologous and normal horse sera thus far tested.
When the auxiliary antibody is mixed in vitro with an antimeningococcus horse serum which by itself is capable of irregular neutralization in a high titer the effect is as follows:
The IN titer of the mixture is increased; the mixture acquires the power of complete neutralization (CN titer) of large numbers of toxic units; it differs in its potency for filtrates of various serological groups.
However, the auxiliary antibody does not exhibit its effect in mixtures with antimeningococcus sera unless the latter contain neutralizing antibodies of sufficient potency and concentration.
The employment of the auxiliary antibody enables one to express the neutralizing value of antimeningococcus sera in terms of complete neutralization and fhus gives an accurate method for their comparative evaluation.
It has been shown in previous communications that the potency of toxic filtrates fluctuates in storage. This considerably handicaps the studies on neutralizing antibodies of sere. Inasmuch as in recent observations the CN titer of mixtures of antimeningococcus sere with the auxiliary antibody appeared to be quite stable, * an opportunity presents itself to titrate the potency of filtrates against a "stock" standard serum and thus determine the toxic titer of filtrates more accurately than by direct titrations.
It remains to be seen whether the reinforcement of antimeningococcus horse sere by means of the auxiliary antibody increases their therapeutic value.
This paper also includes data on a non-specific neutralizing factor of the following characteristics:
1. It is present in a heterologous immune serum (i.e. anticoli horse serum).
2. It is not associated with specific antimeningococcus antibodies (i. e. agglutinins and precipitins).
3. It apparently displays no serological group specificity. 4. It gives complete neutralization of meningococcus reacting factors in multiple proportions.
5. Its neutralizing effect is not displayed when mixed with an antimeningococcus serum of low potency.
6. It is not complement and not associated with anticomplementary properties of horse sere.
These properties have to be differentiated from those of the specific neutralizing antibodies of antimeningococcus sere (8, 9) . The latter are stimulated by immunization with meningococcus antigens; they exhibit species, serological group, and variant specificity; they are obtained in high potency with considerable difficulties; and in most instances they neutralize completely only small numbers of toxic units, but are capable of incomplete neutralization of considerable amounts of toxic filtrates. When multiples of a given amount of antimeningococcus serum are tested there is a proportionate increase in the titer of irregular neutralization but no proportionate increase in the CN titer.
Work is in progress to determine the nature of the non-specific neutralizing factor and also to establish its relations to the auxiliary antibody.
SUMMARY
In this paper there is described an antibody auxiliary to the neutralization of meningococcus reacting factors. The presence of the antibody facilitates studies on neutralizing potency of antimeningococcus sera.
There is also reported a non-specific neutralizing factor of a heterologous immune serum, which can be differentiated from specific neutralizing antibodies of antimeningococcus sera. Its nature and connection with the auxiliary antibody remain to bedetermined. 
